WNT signalling pathways as therapeutic targets in cancer
about
Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt SignalingPtk7 and Mcc, Unfancied Components in Non-Canonical Wnt Signaling and CancerMammary Development and Breast Cancer: A Wnt PerspectiveWnt Signaling in Renal Cell CarcinomaAnti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalControl of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in CancerEnvironmental Ligands of the Aryl Hydrocarbon Receptor and Their Effects in Models of Adult Liver Progenitor CellsFrizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat CancerRho, ROCK and actomyosin contractility in metastasis as drug targetsSurvivin and Tumorigenesis: Molecular Mechanisms and Therapeutic StrategiesDevelopmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancerEchoes of the embryo: using the developmental biology toolkit to study cancerMechanisms of Hippo pathway regulationMicroRNA Regulation of Human Breast Cancer Stem CellsHepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesTargeting Wnt/β-catenin pathway in hepatocellular carcinoma treatmentThe mutational landscape of hepatocellular carcinomaDevelopment of anticancer agents targeting the Wnt/β-catenin signalingMolecular classification of gastric cancer: Towards a pathway-driven targeted therapyGenomically driven precision medicine to improve outcomes in anaplastic thyroid cancerCullin family proteins and tumorigenesis: genetic association and molecular mechanismsNovel hepatocellular carcinoma molecules with prognostic and therapeutic potentialsCancer therapy with phytochemicals: evidence from clinical studiesEmerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancerIdentifying and targeting tumor-initiating cells in the treatment of breast cancerHarnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesisMolecular alterations and biomarkers in colorectal cancerCurrent Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible CrosstalkmicroRNA regulation of Wnt signaling pathways in development and diseaseGSK-3 as potential target for therapeutic intervention in cancerCancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectivesWnt pathway activation increases hypoxia tolerance during developmentThe EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma.Effects of titanium dioxide nanoparticles on human keratinocytesOckham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancerThe possibility of clinical sequencing in the management of cancerToward precision medicine of breast cancerCrosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during InflammationWnt Signaling in Cell Motility and Invasion: Drawing Parallels between Development and CancerWnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches
P2860
Q26738491-3C7733DD-97A0-46BD-B06D-AD8A3098A783Q26738712-2E863328-9A50-4443-801A-810661639CEDQ26740086-1B61C847-92B7-4139-8DA8-B4B163352764Q26744312-E1F2C0DE-D709-4D65-BFC6-78D498BE6072Q26744536-673A99D5-E5E9-4CDA-99B8-0BA21311248DQ26747432-5EBFA93F-2E11-44AB-BC7E-202749646AB2Q26747621-FD001944-67CF-4EC8-9EA9-35EF997E8428Q26747651-85CBAAD1-6965-447B-B510-271F7EE072F9Q26751189-A4AED631-3732-4BBB-B885-AA0C006A2BA9Q26766250-87D1C15B-B9B8-494E-B79C-4D366887843BQ26766266-FEF3CFBA-ADC3-4C54-83B1-56E201C8F072Q26770157-014FC819-91CF-4AC8-8A2D-3CFC3BE8DB1CQ26771285-3EE0E7DE-B0FD-4374-83C7-6F02A116FE2AQ26771792-33F95878-3E49-4BFE-A4AA-7F5B930023E8Q26772317-F8C2EB16-CC69-45B4-9126-668E099564A0Q26774623-81632634-EED8-4952-A5F1-1E087305CC93Q26777478-F59D16F2-B80E-4B1A-B5EC-9A2AC44BFFB4Q26781898-37B00365-E90C-492D-8F43-C69DE2C06D1BQ26798420-131B89F5-E6FD-4773-8CDF-327C40614F3FQ26820880-879D7916-A754-47CF-AE92-66FFC5CFD34DQ26822657-9DE0B006-CEDC-43AF-8EDB-18BF0FBBAF44Q26824909-9BED19E1-EB65-40E8-B857-694B8572C8D2Q26827407-2F3E37A1-F0A4-47A8-B285-92E65BB0E426Q26829126-2B820716-2E76-48EE-A62B-EFE04CA10F50Q26851827-0F593D35-557D-463D-934A-7F869CA42974Q26861766-A49F4490-04D1-40A1-9774-AA0F915DD936Q26862317-C4448F7C-13EF-485B-BDAC-E31563AD94F2Q26865911-123BA475-D19B-41EF-AB5C-2FAEAE9D25BAQ27011654-FD9F6562-D036-4E6F-9F1F-8B84CC67EDA3Q27013811-B16939F7-ED94-4D8E-B3CB-8AC9FB54C01DQ27024651-431C783B-29ED-4926-9588-0BA1A5E41F1AQ27317418-B70C073E-D24B-45F7-876B-DBC3EEC665A9Q27852536-57D40C16-6ECE-452E-B7E9-FFE5559C9DD9Q27908495-736D2A34-F87C-4988-99C1-A51189F549BDQ28067777-C4D1F318-11B2-4392-985B-365D084CE8C4Q28072144-88D1846D-5108-4DBC-8567-885A55AF2C14Q28073967-DCB68431-E41F-4419-9089-72AA8947644AQ28074708-0D5F60EF-3857-46CC-9F1D-1A78DAA8FEEFQ28077330-311B680B-3F61-4461-9595-EFA5CAB33A8EQ28077396-81A99A9E-689C-4166-8206-A18F5CAE3640
P2860
WNT signalling pathways as therapeutic targets in cancer
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
WNT signalling pathways as therapeutic targets in cancer
@ast
WNT signalling pathways as therapeutic targets in cancer
@en
type
label
WNT signalling pathways as therapeutic targets in cancer
@ast
WNT signalling pathways as therapeutic targets in cancer
@en
prefLabel
WNT signalling pathways as therapeutic targets in cancer
@ast
WNT signalling pathways as therapeutic targets in cancer
@en
P3181
P356
P1476
WNT signalling pathways as therapeutic targets in cancer
@en
P2093
Jamie N Anastas
P2888
P3181
P356
10.1038/NRC3419
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1003577201